Sponsored by

​Boston Scientific CEO reaped $33M in total compensation in 2015

Mike Mahoney earned $11.6 million in total compensation last year, plus another $20.9 million worth of stock that vested during the year 2015.

Updated: Feds charge Cambridge drug firm Aveo, former execs with misleading investors

The SEC says today that executives at Aveo Pharmaceuticals committed fraud by failing to tell investors that the FDA explicitly recommended a second late-stage trial of its kidney cancer drug a year before that drug was rejected.

​Ariad to lay off 90 people across the company in cost-cutting measure

The cuts represent a quarter of the drug company's total workforce.

Southcoast Health cutting dozens of jobs on heels of expensive IT upgrade

Southcoast employees were notified of the cut Wednesday morning. The cuts come as the hospital negotiates a merger with Care New England, a four-hospital system in Rhode Island.

Early diabetes detector developed in Durham to be sold in Europe

Colorado life science company in big financing deal